Lishen Shan

机构：China Medical University · ORCID：0009-0005-8491-2449

发表论文 48 篇 · 总被引 640 次 · h-index 13

代表论文

• ITPRIPL1 binds CD3ε to impede T cell activation and enable tumor immune evasion (2024 · Cell · 被引 56)
• Dietary patterns, uric acid levels, and hyperuricemia: a systematic review and meta-analysis (2023 · Food & Function · 被引 34)
• Human bone marrow-mesenchymal stem cell-derived exosomal microRNA-188 reduces bronchial smooth muscle cell proliferation in asthma through suppressing the JARID2/Wnt/β-catenin axis (2022 · Cell Cycle · 被引 33)
• Per- and polyfluoroalkyl substances and human health outcomes: An umbrella review of systematic reviews with meta-analyses of observational studies (2024 · Journal of Hazardous Materials · 被引 20)
• Efficacy and safety of omalizumab combined with allergen immunotherapy in children with moderate to severe allergic asthma (2024 · International Forum of Allergy & Rhinology · 被引 12)
• Synthetic approaches and application of representative clinically approved fluorine-enriched anti-cancer medications (2024 · European Journal of Medicinal Chemistry · 被引 10)